Michael Favish serves as Executive at Guardion Health Sciences, Inc., where they oversee executive responsibilities. Since joining the company, Michael Favish has executed 7 insider transactions totaling $821.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 9, 2019 involved receiving (via award) 1,000 shares valued at $4.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 9, 2019 | GHSI | $4.0K | Award | 1,000 | $4.00 | Discretionary |
| Dec 31, 2016 | NONE | $411.0K | Purchase | 684,933 |
Michael Favish currently holds 1,000 shares of Guardion Health Sciences, Inc. (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Favish has been a net buyer of NONE stock. They have purchased $821.9K and sold $0 worth of shares.
Michael Favish's most recent insider trade was on Apr 9, 2019, when they sold 1,000 shares at $4.00 per share.
Get notified when new Form 4 filings are submitted
| $0.60 |
| Discretionary |
| Dec 31, 2016 | NONE | $0 | Award | 50,000 | $N/A | Discretionary |
| Dec 31, 2016 | NONE | $0 | Award | 10,000 | $N/A | Discretionary |
| Dec 31, 2016 | NONE | $0 | Award | 50,000 | $N/A | Discretionary |
| Dec 31, 2016 | NONE | $0 | Award | 10,000 | $N/A | Discretionary |
| Dec 31, 2016 | NONE | $411.0K | Purchase | 684,933 | $0.60 | Discretionary |